Inhibitory effect of the test food on ultraviolet-induced skin damage.

Not Applicable

• Conditions: Healthy volunteer

• Registration Number: JPRN-UMIN000041618
• Lead Sponsor: DRC Co., Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-08-31
• Study Completion: 2020-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Not provided

Exclusion Criteria

1)Subjects with photosensitivity disorder. 2)Subjects who take medicine that affect light sensitivity of skin. 3)Subjects who regularly go to a dermatology office. 4)Subjects who continuously take medicine, quasi-medicine, functional food or supplement which advocate or emphasize efficacy for which is evaluated in the trial. 5)Subjects who have skin disease or abnormality such as atopic dermatitis. 6)Subjects who may perform physical activity in the sunlight for a long time during test period. 7)Subjects who take anti-inflammatory medicine at least once a month. 8)Shift worker. 9)Subjects who receive or require medical or prophylactic treatment. 10)Subjects who have a medical history for severe disease or abnormality in glucose or lipid metabolism, endocrine or nerve system, or for psychiatric disorder. 11)Subjects who have a medical history or present illness of serious hepatopathy, kidney damage, heart disease, hematological and blood disease. 12)Subjects who have a medical history of serious gastrointestinal disease. 13)Subjects who have a medical history of alcoholism or drug addiction. 14)Subjects who have risk for allergy related to test foods. 15)Subjects who have s damage or inflammation on the measurement sites. 16)Subjects who have Severe anemia. 17)Subjects whose BMI is over 30.0 kg/m2 18)Subjects who smoke. 19)Subjects who will develop seasonal allergy symptoms like hay fever and take medicine. 20)Subjects who had been conducted an operation or beauty treatment on the measurement sites within the past 6 months. 21)Subjects who frequently intake food which might affect skin color. 22)Subjects who show abnormality in blood test during screening and test period. 23)Possible pregnancy, pregnancy and lactation 24)Subjects who were involved in another clinical studies within 4 weeks prior to the trial, or who will participate in another clinical studies. 25)Subjects who are judged to be inappropriate for the study by the principal investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified